#USA #Dallas #Clinical Trials #Cedar Health #Jody Staggs

Cedar Health Research Appoints Jody Staggs as CEO

Cedar Health Research, a dynamic player in the clinical research field, has recently appointed Jody Staggs as its new Chief Executive Officer effective September 14, 2026. This strategic move aims to enhance the organization's mission of making clinical trials more accessible to community populations across the Dallas-Fort Worth area.

With over 20 years of experience in the life sciences industry, Staggs steps into this role with a wealth of knowledge, particularly from his previous position as CEO of SWK Holdings Corporation. During his time at SWK, he successfully steered the company towards becoming a trusted ally in the life sciences sector. His track record in business leadership and public company administration sets a promising tone for Cedar's future.

Cedar Health Research operates five clinical research sites focused on bringing trials directly into the communities where patients live, an approach designed to increase diversity among trial participants. The organization has emphasized its dedication to incorporating populations that have historically faced barriers in clinical research, such as minorities and underrepresented groups. For instance, Cedar recently expanded its reach with a new clinical research site embedded within Texas Native Health in Dallas, aimed specifically at enhancing participation among American Indian and Alaska Native patients.

In his statement, Staggs acknowledged the unique environment Cedar has cultivated. “Cedar has built something special—a talented, mission-driven team, strong relationships across the clinical research ecosystem, and a model designed to bring research opportunities to the communities that need them the most,” he said.

Under his leadership, Cedar plans to not only continue expanding its patient base but also to fortify existing partnerships with healthcare providers and sponsors. Staggs expresses enthusiasm about learning from the Cedar team and the stakeholders involved, reinforcing a collaborative environment that bolsters Cedar's ongoing commitment towards inclusive clinical research.

Staggs succeeds Dr. Mimi Fenton, who has led Cedar since 2024. Under her governance, the company flourished, expanding its capabilities and reinforcing its mission of increasing access to clinical trials. Staggs shared gratitude for Dr. Fenton's contributions during a critical time for the organization.

As a community-focused entity, Cedar Health Research recognizes the importance of ensuring clinical trial populations reflect the demographics of those affected by various conditions. This mission aligns seamlessly with the growing recognition of the need for diversity in clinical research, a principle that is becoming increasingly pivotal in the ongoing quest for medical advancements.

Cedar Health Research remains committed to providing valuable research options that empower patients and their communities. With Staggs at the helm, the organization is keen to streamline its processes and strengthen its outreach initiatives. By fostering more inclusive participation in clinical trials, Cedar aims to not only advance scientific knowledge but also improve healthcare outcomes for marginalized populations.

For anyone looking to know more about Cedar Health Research and its initiatives, the organization’s official website offers insights into its ongoing projects and partnerships. With the recent leadership change, all eyes will be on Cedar as it embarks on this new chapter under Jody Staggs’ leadership.